mi519a-2: A Non-coding RNA Molecule with Potential as A Drug Target Or Biomarker for Cancer

Target Name: MIR519A2

NCBI ID: G574500

MIR519A2

mi519a-2: A Non-coding RNA Molecule with Potential as A Drug Target Or Biomarker for Cancer

MicroRNA (miRNA) 519a-2 is a non-coding RNA molecule that plays a critical role in regulating various cellular processes. It is a key regulator of cell proliferation and has been implicated in a variety of diseases, including cancer. Despite its importance, little is known about mi519a-2 and how it functions in the cell.

The discovery of mi519a-2

The discovery of mi519a-2 was made by a team of researchers at the University of California, San Diego. They used a technique called RNA sequencing (RNA-seq) to analyze the expression of mi519a-2 in various cell types. They found that mi519a-2 was highly expressed in human breast cancer cells and that it was downregulated in human prostate cancer cells.

The implications of these findings are significant. The researchers suggest that mi519a-2 may be a useful drug target or biomarker for the treatment of prostate cancer and other cancers.

Function and mechanism of mi519a-2

Mi519a-2 is a non-coding RNA molecule that is made up of 20 amino acid residues. It has been shown to play a role in regulating cellular processes such as cell proliferation, apoptosis (programmed cell death), and gene expression.

One of the most interesting functions of mi519a-2 is its role in cell proliferation. The researchers have shown that mi519a-2 can inhibit the activity of the protein kinase PDGFR, which is involved in cell proliferation. This suggests that mi519a-2 may be a useful drug target for the treatment of cancer.

mi519a-2 has also been shown to play a role in apoptosis. The researchers have shown that mi519a-2 can induce apoptosis in various cell types and that it is involved in the regulation of cell death.

mi519a-2 has also been shown to play a role in gene expression. The researchers have shown that mi519a-2 can interact with various proteins and that it can regulate the expression of various genes.

Disease associations with mi519a-2

Despite the fact that mi519a-2 has been shown to play a role in a variety of diseases, including cancer, little is known about its specific mechanisms of action. Further research is needed to fully understand the functions of mi519a-2 and its potential as a drug target or biomarker.

In conclusion, the discovery of mi519a-2 is a promising development in the field of cancer research. Further research is needed to fully understand its functions and potential as a drug target or biomarker.

Protein Name: MicroRNA 519a-2

The "MIR519A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR519A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets